Acute Subdural Hematoma

Part of paid clinical trials in Dallas, Texas.

Sponsor
Methodist Health System
Study ID
NCT07490197
Status
Recruiting
Apply to this trial

Conditions

  • Trauma

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Medical/Phenotype Data Collection Procedures & Data to be Collected — OTHER
    TheMethodist Dallas Medical Center Trauma Registry will be queried for demographic information, diagnosis codes, admission dates, traumatic injury characteristics, surgical procedures, comorbidities, inpatient outcomes, complications, consultations, discharge location, and mortality. Additional laboratory values will be abstracted from Epic through retrospective chart review.

Study Details

This retrospective data repository will serve as a means to aggregate and analyze standard surgical interventions and Middle Meningeal Arteryembolization as suitable treatment options for Acute Subdural Hematoma.

Key Dates

Start date
Feb 28, 2026
Status verified
Feb 2026
Primary completion
Feb 28, 2027
Completion
Feb 29, 2028

Study Design

Enrollment
100 participants (estimated)

Arms

  • Arm: Total Number and Description of Study Sites/Total Number of Subjects
    This study will include all trauma patients who meet registry inclusion and arrive at the Methodist Dallas Medical Center trauma bay with Acute subdural hematoma . Enrollment will terminate once adequate number of interventions have been observed for clinical significance to be established.

Primary Outcome Measure

Total Number and Description of Study Sites/Total Number of Subjects [ Time Frame: 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Methodist Dallas Medical Center- Clinical Research InstituteDallasTexas75203
Colette Ngo Ndjom
[email protected]
214-947-1289
Kavya Mankulangara
[email protected]
214-947-4604

Find similar trials in Dallas, TX

By research site
Methodist Dallas Medical Center- Clinical Research Institute· Dallas, TX

Related Studies